Edmund Dunn insider trades
Open-market stock purchases and sales by Edmund Dunn, Principal Accounting Officer at Monte Rosa Therapeutics, Inc, from SEC Form 4 filings since Jan 2, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 4, 2026 | GLUE Monte Rosa Therapeutics, Inc | Sold | $2.5K |
| Mar 2, 2026 | GLUE Monte Rosa Therapeutics, Inc | Sold | $9.4K |
| Mar 2, 2026 | GLUE Monte Rosa Therapeutics, Inc | Bought (not open market) | — |
| Feb 27, 2026 | GLUE Monte Rosa Therapeutics, Inc | Sold | $456K |
| Feb 27, 2026 | GLUE Monte Rosa Therapeutics, Inc | Bought (not open market) | — |
| Jan 5, 2026 | GLUE Monte Rosa Therapeutics, Inc | Sold | $15.8K |
Companies traded
- GLUE Monte Rosa Therapeutics, Inc: 7 sales, last Mar 4, 2026